At least the drilling results are speaking loud and clear...Still undervalued at $117m and $23m cash. Only 3 out of 15 wells drilled for 2008.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%